Use of Fluticasone Propionate/Salmeterol Combination Post Emergency Department Visit
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 6,139
- 主要终点
- Number of Participants With an Asthma-related Event Occurring Between 1 and 6 Months Following the Index Event
研究概览
简要总结
The objective of this study is to compare readmission to the emergency department for asthma in asthma patients who receive treatment with fluticasone propionate and salmeterol oral inhaler after an initial emergency department visit using a retrospective observational cohort study design.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 12 Years 至 —（Child, Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Subjects with asthma as determined by ICD-9 codes and asthma drug use
- •at least 12 years of age
- •discharged from an initial Emergency Department visit within 12 months
排除标准
- •Subjects with COPD or treatment for COPD
研究组 & 干预措施
Fluticasone propionate/salmeterol combination ED MD
Asthma subjects discharged from an institution after treatment for severe asthma exacerbation that receive fluticasone propionate/salmeterol combination from the ED physician
干预措施: Fluticasone propionate/salmeterol combination ED MD (Drug)
Fluticasone propionate/salmeterol combination OP MD
Asthma subjects discharged from an institution after treatment for severe asthma exacerbation that receive fluticasone propionate/salmeterol combination from the OP physician
干预措施: Fluticasone propionate/salmeterol combination OP MD (Drug)
结局指标
主要结局
Number of Participants With an Asthma-related Event Occurring Between 1 and 6 Months Following the Index Event
时间窗: Data were collected during a 4-year period from January 1, 2004 to December 31, 2008.
A subsequent asthma-related inpatient (IP) visit or emergency department (ED) visit were defined as visits within 6 months of the index event. The index event was defined as an asthma-related hospitalization or ED visit occuring between 2004 and 2008.
次要结局
未报告次要终点